Kay Kwang-ae Kim

Array ( [id] => 2870788 [patent_doc_number] => 05162505 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-11-10 [patent_title] => 'Proteins modified with positively charged carriers and compositions prepared therefrom' [patent_app_type] => 1 [patent_app_number] => 7/409150 [patent_app_country] => US [patent_app_date] => 1989-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6665 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/162/05162505.pdf [firstpage_image] =>[orig_patent_app_number] => 409150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2851607 [patent_doc_number] => 05104976 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-04-14 [patent_title] => 'Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a Schiff\'s base and in-vivo prolonged action immunotoxins containing such a glycoprotein' [patent_app_type] => 1 [patent_app_number] => 7/404052 [patent_app_country] => US [patent_app_date] => 1989-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14731 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/104/05104976.pdf [firstpage_image] =>[orig_patent_app_number] => 404052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2848437 [patent_doc_number] => 05106956 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-04-21 [patent_title] => 'Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and reduction, and in vivo prolonged-action immunotoxins containing such a glycoprotein' [patent_app_type] => 1 [patent_app_number] => 7/404611 [patent_app_country] => US [patent_app_date] => 1989-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16681 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/106/05106956.pdf [firstpage_image] =>[orig_patent_app_number] => 404611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2782324 [patent_doc_number] => 05154924 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-10-13 [patent_title] => 'Transferrin receptor specific antibody-neuropharmaceutical agent conjugates' [patent_app_type] => 1 [patent_app_number] => 7/404089 [patent_app_country] => US [patent_app_date] => 1989-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5674 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/154/05154924.pdf [firstpage_image] =>[orig_patent_app_number] => 404089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2673183 [patent_doc_number] => 05026827 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-06-25 [patent_title] => 'Amphetamine-protein complex as immunogen for obtaining antibodies specific to methamphetamine' [patent_app_type] => 1 [patent_app_number] => 7/401247 [patent_app_country] => US [patent_app_date] => 1989-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 6016 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/026/05026827.pdf [firstpage_image] =>[orig_patent_app_number] => 401247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2825614 [patent_doc_number] => 05169933 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-12-08 [patent_title] => 'Covalently-linked complexes and methods for enhanced cytotoxicity and imaging' [patent_app_type] => 1 [patent_app_number] => 7/390241 [patent_app_country] => US [patent_app_date] => 1989-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12533 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/169/05169933.pdf [firstpage_image] =>[orig_patent_app_number] => 390241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2823703 [patent_doc_number] => 05169835 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-12-08 [patent_title] => 'Pregancy specific proteins applications' [patent_app_type] => 1 [patent_app_number] => 7/390409 [patent_app_country] => US [patent_app_date] => 1989-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 13 [patent_no_of_words] => 11316 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/169/05169835.pdf [firstpage_image] =>[orig_patent_app_number] => 390409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2882905 [patent_doc_number] => 05108987 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-04-28 [patent_title] => 'Conjugates of proteins with anti-tumor agents' [patent_app_type] => 1 [patent_app_number] => 7/387463 [patent_app_country] => US [patent_app_date] => 1989-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3885 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/108/05108987.pdf [firstpage_image] =>[orig_patent_app_number] => 387463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2776727 [patent_doc_number] => 05151412 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-09-29 [patent_title] => 'Pharmaceutically active conjugates having improved body tissue binding specificity' [patent_app_type] => 1 [patent_app_number] => 7/359662 [patent_app_country] => US [patent_app_date] => 1989-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11958 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/151/05151412.pdf [firstpage_image] =>[orig_patent_app_number] => 359662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2800687 [patent_doc_number] => 05114711 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-05-19 [patent_title] => 'Covalently linked polypeptide cell modulators such as interferon-lymphotoxin conjugates' [patent_app_type] => 1 [patent_app_number] => 7/379509 [patent_app_country] => US [patent_app_date] => 1989-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 9120 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/114/05114711.pdf [firstpage_image] =>[orig_patent_app_number] => 379509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2820431 [patent_doc_number] => 05094848 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-03-10 [patent_title] => 'Cleavable diphosphate and amidated diphosphate linkers' [patent_app_type] => 1 [patent_app_number] => 7/373426 [patent_app_country] => US [patent_app_date] => 1989-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11492 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/094/05094848.pdf [firstpage_image] =>[orig_patent_app_number] => 373426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2822442 [patent_doc_number] => 05094950 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-03-10 [patent_title] => 'Diethylenetriamine pentaacetic acid derivatives' [patent_app_type] => 1 [patent_app_number] => 7/362370 [patent_app_country] => US [patent_app_date] => 1989-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8886 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/094/05094950.pdf [firstpage_image] =>[orig_patent_app_number] => 362370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2812205 [patent_doc_number] => 05122368 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-06-16 [patent_title] => 'Anthracycline conjugates having a novel linker and methods for their production' [patent_app_type] => 1 [patent_app_number] => 7/353729 [patent_app_country] => US [patent_app_date] => 1989-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 46 [patent_no_of_words] => 20591 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/122/05122368.pdf [firstpage_image] =>[orig_patent_app_number] => 353729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2745554 [patent_doc_number] => 05011913 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-04-30 [patent_title] => 'Diphosphonate-derivatized macromolecules' [patent_app_type] => 1 [patent_app_number] => 7/350420 [patent_app_country] => US [patent_app_date] => 1989-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7345 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/011/05011913.pdf [firstpage_image] =>[orig_patent_app_number] => 350420 [rel_patent_id] =>[rel_patent_doc_number] =>)